Serial Number
98354497
Owner
Neurocrine Biosciences, Inc.Attorney
Allison Strickland RickettsFiling Date
Jan 12, 2024
Serial #98354497 Trademark
Serial Number: 98354497
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
6027 Edgewood Bend Court
San Diego, CA 92130
Entity Type: 03
Legal Representation
Correspondence Address
Allison Strickland Ricketts Fross Zelnick Lehrman & Zissu, P.C.
151 West 42nd St., 17th Fl.
New York, NY 10036
United States
Trademark Details
Filing Date
January 12, 2024
Registration Date
Not Registered
Published for Opposition
March 11, 2025
Goods & Services
pharmaceutical preparations for human use for the treatment of adrenal insufficiency; pharmaceutical preparations for human use for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for human use for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions
Providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders
providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; Conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders; conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results
